The ACRB is proud to be coordinating an exciting new study created to improve the early detection and diagnosis of breast cancer using a single blood sample. Designed by University of Calgary researcher-led Syantra, the ‘Identification of Breast Cancer from a Blood Sample (IDBC)’ study is looking to recruit 1,200 women who have either been referred for a biopsy or who have had a normal mammogram or negative physical breast exam within the last 9 months.
If you would like to participate, you will be asked to:
1. Discuss the project and eligibility with our IDBC Study Coordinator, and if you agree to participate, complete and sign a consent form. Consenting to the IDBC study will give permission for the storage and use of your de-identified blood sample and health information for development of this blood test.
2. Provide a voluntary blood sample (1-3 teaspoons) at a pre-determined CLS location. This can be done at the same time as other blood work, but must be completed before any intervention (such as a biopsy) is performed.
3. Complete a short questionnaire to provide additional information about you and your health history.
If you have any questions or would like more information, please contact our IDBC Study Coordinator at 403.521.3604 or email@example.com, and also read through the IDBC Consent Form, IDBC Questionnaire or IDBC Brochure.
Thank you for considering this important study!!
Read more about the IDBC study here: https://myleapmagazine.ca/2018/07/26/new-blood-test-improve-accuracy-breast-cancer-screening/.